3-n-methylspiperone has been researched along with nalmefene in 1 studies
| Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (nalmefene) | Trials (nalmefene) | Recent Studies (post-2010) (nalmefene) |
|---|---|---|---|---|---|
| 155 | 6 | 7 | 385 | 85 | 173 |
| Protein | Taxonomy | 3-n-methylspiperone (IC50) | nalmefene (IC50) |
|---|---|---|---|
| kappa-type opioid receptor isoform 1 | Homo sapiens (human) | 0.6395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakiuchi, T; Kosugi, T; Kreek, MJ; Nishiyama, S; Tsukada, H; Unterwald, EM | 1 |
1 other study(ies) available for 3-n-methylspiperone and nalmefene
| Article | Year |
|---|---|
Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain.
Topics: Animals; Benzazepines; Brain Chemistry; Cerebral Cortex; Dopamine Agonists; Dopamine Antagonists; Male; Naltrexone; Narcotic Antagonists; Neostriatum; Pilot Projects; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1997 |